Biote [BTMD] vs Tenet Healthcare [THC] Detailed Stock Comparison

Biote Corp.

NASDAQ
Loading...

Tenet Healthcare Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Biote Corp. wins in 7 metrics, Tenet Healthcare Corporation wins in 13 metrics, with 0 ties. Tenet Healthcare Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Biote Corp. Tenet Healthcare Corporation Better
P/E Ratio (TTM) 3.08 12.17 Biote Corp.
Price-to-Book Ratio -1.39 3.88 Tenet Healthcare Corporation
Debt-to-Equity Ratio -2.18 160.79 Tenet Healthcare Corporation
PEG Ratio -0.06 10.76 Tenet Healthcare Corporation
EV/EBITDA 4.37 7.05 Biote Corp.
Profit Margin (TTM) 14.07% 6.60% Biote Corp.
Operating Margin (TTM) 9.40% 17.46% Tenet Healthcare Corporation
EBITDA Margin (TTM) 9.40% 17.46% Tenet Healthcare Corporation
Return on Equity -53.66% 27.02% Tenet Healthcare Corporation
Return on Assets (TTM) 19.06% 8.04% Biote Corp.
Free Cash Flow (TTM) $28.33M $2.53B Tenet Healthcare Corporation
1-Year Return -34.92% 6.26% Tenet Healthcare Corporation
Price-to-Sales Ratio (TTM) 0.38 0.77 Biote Corp.
Enterprise Value $163.97M $32.68B Tenet Healthcare Corporation
EV/Revenue Ratio 0.85 1.53 Biote Corp.
Gross Profit Margin (TTM) 68.03% 81.73% Tenet Healthcare Corporation
Revenue per Share (TTM) $6 $236 Tenet Healthcare Corporation
Earnings per Share (Diluted) $0.74 $15.48 Tenet Healthcare Corporation
Beta (Stock Volatility) 1.29 1.50 Biote Corp.
Short % of Float 7.11% 3.55% Tenet Healthcare Corporation

Biote Corp. vs Tenet Healthcare Corporation Stock Performance Analysis

Loading Price Chart...

BTMD
THC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Biote Corp.-8.54%-3.85%14.21%63.04%-14.12%-8.91%
Tenet Healthcare Corporation2.55%9.88%-8.92%-18.33%-9.23%-10.20%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Biote Corp.-34.92%-58.66%-75.15%-75.52%-75.52%-75.52%
Tenet Healthcare Corporation6.26%122.70%164.92%543.08%581.20%489.27%

Performance & Financial Health Analysis: Biote Corp. vs Tenet Healthcare Corporation

MetricBTMDTHC
Market Information
Market Cap i$84.97M$16.50B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i231,7701,231,387
90 Day Avg. Volume i321,1031,117,252
Last Close$2.25$179.11
52 Week Range$1.27 - $4.75$146.60 - $247.21
% from 52W High-52.63%-27.55%
All-Time High$10.52 (May 23, 2022)$247.21 (Mar 05, 2026)
% from All-Time High-78.61%-27.55%
Growth Metrics
Quarterly Revenue Growth-0.07%0.09%
Quarterly Earnings Growth-0.47%0.17%
Financial Health
Profit Margin (TTM) i0.14%0.07%
Operating Margin (TTM) i0.09%0.17%
Return on Equity (TTM) i-0.54%0.27%
Debt to Equity (MRQ) i-2.18160.79
Cash & Liquidity
Book Value per Share (MRQ)$-1.91$48.53
Cash per Share (MRQ)$0.79$33.15
Operating Cash Flow (TTM) i$35.19M$3.54B
Levered Free Cash Flow (TTM) i$13.27M$1.68B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Biote Corp. vs Tenet Healthcare Corporation

MetricBTMD (Apr 26, 2026)THC (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i3.0812.17
Forward P/E i4.0010.76
PEG Ratio i-0.0610.76
Price to Sales (TTM) i0.380.77
Price to Book (MRQ) i-1.393.88
Market Capitalization
Market Capitalization i$84.97M$16.50B
Enterprise Value i$163.97M$32.68B
Enterprise Value Metrics
Enterprise to Revenue i0.851.53
Enterprise to EBITDA i4.377.05
Risk & Other Metrics
Beta i1.291.50
Book Value per Share (MRQ) i$-1.91$48.53

Financial Statements Comparison: Biote Corp. vs Tenet Healthcare Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBTMD (2025)THC (2025)
Revenue/Sales i192.22M21.31B
Cost of Goods Sold i54.86M3.78B
COGS % of Revenue i28.5%17.7%
Gross Profit i137.36M17.53B
Gross Margin i71.5%82.3%
Research & Development iN/AN/A
Operating Income (EBIT) i35.55M3.44B
Operating Margin i18.5%16.1%
EBITDA i39.19M4.68B
EBITDA Margin i20.4%22.0%
Pre-Tax Income i37.58M2.80B
Pre-Tax Income % of Revenue i19.6%13.1%
Income Tax i5.99M433.00M
Income Tax % of Revenue i3.1%2.0%
Net Income (Profit) i31.60M1.41B
Profit Margin i16.4%6.6%

Balance Sheet & Liquidity Metrics

MetricBTMD (2025)THC (2025)
Cash & Equivalents i24.12M2.88B
Total Current Assets i54.67M7.85B
Total Current Assets % of Revenue i28.4%36.8%
Total Current Liabilities i44.99M4.46B
Total Current Liabilities % of Revenue i23.4%20.9%
Long-Term Debt i103.08M13.09B
Long-Term Debt % of Revenue i53.6%61.4%
Total Shareholders Equity i-50.40M8.97B
Retained Earnings i-49.55M4.42B
Retained Earnings % of Revenue i-25.8%20.7%
Property, Plant & Equipment i1.69M6.71B

Cash Flow Statement Comparison

MetricBTMD (2025)THC (2025)
Operating Cash Flow i34.19M3.51B
Operating Cash Flow % of Revenue i17.8%16.5%
Capital Expenditures i-5.02M-972.00M
Free Cash Flow i28.33M2.53B
FCF Margin i14.7%11.9%
Debt Repayment i-6.25M-2.37B
Common Stock Repurchase i-3.37M-1.39B

Short Interest & Institutional Ownership Analysis

MetricBTMDTHC
Shares Short i1.69M2.28M
Short Ratio i4.812.20
Short % of Float i7.11%3.55%
Shares Outstanding i30.71M86.95M
Float Shares i20.26M85.97M
% Held by Insiders i9.77%1.08%
% Held by Institutions i64.32%98.33%
% Held by Public i25.91%0.59%

Dividend Analysis & Yield Comparison: Biote Corp. vs Tenet Healthcare Corporation

MetricBTMDTHC
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A